Can early timed internal atrial defibrillation shocks reduce the atrial defibrillation threshold?

PACE - Pacing and Clinical Electrophysiology

Volumn 22, Issue 8, 1999, Pages 1179-1185

  Fotuhi, Parwis C ^a   Cooper, Randolph A S ^a   Sreenan, Catherine M ^a   Rollins, Dennis L ^a   Smith, William M ^a   Ideker, Raymond E ^a,b  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b Volker Hall B140A ^*  (United States)

Author keywords

Atrial fibrillation; Internal atrial shocks

Indexed keywords

METHACHOLINE CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DEFIBRILLATION; DISEASE SIMULATION; FEMALE; HEART ATRIUM FIBRILLATION; HEART ATRIUM PACING; HEART ELECTROPHYSIOLOGY; MALE; NONHUMAN; SHEEP; TECHNIQUE; TIME; TREATMENT OUTCOME; WAVEFORM;

ANIMALS; ATRIAL FIBRILLATION; DEFIBRILLATORS, IMPLANTABLE; DISEASE MODELS, ANIMAL; ELECTRIC COUNTERSHOCK; ELECTROCARDIOGRAPHY; FEMALE; HEART ATRIA; HEART RATE; INFUSIONS, INTRAVENOUS; MALE; MAXIMUM ALLOWABLE CONCENTRATION; METHACHOLINE CHLORIDE; PARASYMPATHOMIMETICS; REPRODUCIBILITY OF RESULTS; SHEEP; TIME FACTORS;

EID: 0032790454     PISSN: 01478389     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1540-8159.1999.tb00598.x     Document Type: Article

References (23)

1. Jung W, Pfeiffer D, Wolpert C, et al. Which patients do benefit from an implantable atrial defibrillator? (abstract) J Am Coll Cardiol 1996; 27:301A.
2. Pai S, Torres V. Atrial fibrillation: New management strategies. Curr Probl Cardiol 1993; 18:233-300.
3. Wolf PA, Dawber TR, Thomas E Jr, et al. Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: The Framingham study. Neurology 1978; 28:973-977.
4. Levy S, Ricard P, Lau C, et al. Multicenter low energy transvenous atrial defibrillation (XAD) trial. J Am Coll Cardiol 1997; 29:750-755.
5. Lau CP, Tse HF, Lee K, et al. Initial clinical experience of a human implantable atrial defibrillator. PACE 1997; 20:220-225.
6. Alt E, Schmitt C, Ammer R, et al. Initial experience with intracardiac atrial defibrillation in patients with chronic atrial fibrillation. PACE 1994; 17: 1067-1078.
7. Murgatroyd FD, Slade AKB, Sopher SM, et al. Efficacy and tolerability of transvenous low energy cardioversion of paroxysmal atrial fibrillation in humans. J Am Coll Cardiol 1996; 25:1347-1353.
8. Cooper RAS, Alferness CA, Smith WM, et al. Internal cardioversion of atrial fibrillation in sheep. Circulation 1993; 87:1673-1686.
9. Cooper RAS, Johnson EE, Wharton M. Internal atrial defibrillation in humans. Improved efficacy of biphasic waveforms and the importance of phase duration. Circulation 1997; 95:1487-1496.
10. Jung W, Tebbenjohanns J, Wopert C, et al. Safety, efficacy, and pain perception of internal atrial defibrillation in humans. Circulation 1995; 92:1-472.
11. Steinhaus DM, Cardinal D, Monegeon L, et al. Atrial defibrillation: Are low energy shocks acceptable to patients? (abstract) PACE 1996; 19:625.
12. Lok NS, Lau CP, Tse HF, et al. Clinical shock tolerability and effect of different right atrial electrode locations on efficacy of low energy human transvenous atrial defibrillation using an implantable lead system. J Am Coll Cardiol 1997; 30:1324-1330.
13. Tomassoni G, Newby KH, Kearney MM, et al. Testing different biphasic waveforms and capacitances: Effect on atrial defibrillation threshold and pain perception. J Am Coll Cardiol 1996; 28: 695-699.
14. Wiggers CJ. The mechanism and nature of ventricular fibrillation. Am Heart J 1940; 20:399-412.
15. Chen P-S, Wolf PD, Dixon EG, et al. Mechanism of ventricular vulnerability to single premature stimuli in open-chest dogs. Circ Res 1988; 62:1191-1209.
16. Strobel JS, KenKnight BH, Rollins DL, et al. The effects of ventricular fibrillation duration and site of initiation on the defibrillation threshold during early ventricular fibrillation. J Am Coll Cardiol 1998; 32:521-527.
17. Cooper RAS, Smith WM, Ideker RE. Internal cardioversion of atrial fibrillation: Marked reduction in defibrillation threshold with dual current pathways. Circulation 1997; 96:2693-2700.
18. Alt EU, Fotuhi PC, Callihan RL, et al. Improved defibrillation threshold with a new epicardial carbon electrode compared with a standard epicardial titanium patch. Circulation 1995; 91:445-450.
19. Bourland JD, Tacker WA Jr, Wessale JL, et al. Sequential pulse defibrillation for implantable defibrillators. Med Instrum 1986; 20:138-142.
20. Sweeney RJ, Gill RM, Reid PR. Characterization of refractory period extension by transcardiac shock. Circulation 1991; 83:2057-2066.
21. Dillon SM. Optical recordings in the rabbit heart show that defibrillation strength shocks prolong the duration of depolarization and the refractory period. Circ Res 1991; 69:842-856.
22. Aizawa Y, Niwano S, Chinushi M, et al. Incidence and mechanism of interruption of reentrant ventricular tachycardia with rapid ventricular pacing. Circulation 1992; 85:589-595.
23. Callans DJ, Hook BG, Mitra RL, et al. Characterization of return cycle responses predictive of successful pacing-mediated termination of ventricular tachycardia. J Am Coll Cardiol 1995; 25: 47-53.